首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Simultaneous determination of nitrendipine and one of its metabolites in plasma samples by gas chromatography with electron-capture detection.
【24h】

Simultaneous determination of nitrendipine and one of its metabolites in plasma samples by gas chromatography with electron-capture detection.

机译:气相色谱-电子捕获检测法同时测定血浆样品中的尼群地平及其代谢物之一。

获取原文
获取原文并翻译 | 示例
           

摘要

A sensitive method for GC-ECD simultaneous determination of nitrendipine and its pyridine metabolite M1 in human plasma is described. Felodipine was used as the internal standard. The plasma samples were extracted with toluene. One microlitre of the extract was injected onto the capillary column (polymethylsiloxane) and measured with electron-capture detector. The developed method showed to be linear over the range 0.25-70 for nitrendipine and 0.3-61 ng/ml for its metabolite M1 with an inter-day and intra-day precision in terms of R.S.D. lower than 8% except the concentrations near lowest limit of quantification (LLOQ) (<11% R.S.D.). The LLOQ for nitrendipine was 0.25 and 0.3 ng/ml for its metabolite, respectively. The analytical recovery was 94% for nitrendipine and 89% for its pyridine metabolite M1. This GC-ECD method was developed for being used in clinical pharmacokinetic studies.
机译:描述了一种用于GC-ECD同时测定人血浆中尼群地平及其吡啶代谢物M1的灵敏方法。非洛地平用作内标。血浆样品用甲苯萃取。将一微升提取物注入毛细管柱(聚甲基硅氧烷)中,并用电子捕获检测器进行测量。经开发的方法显示,尼群地平的代谢产物M1在0.25-70范围内线性变化,代谢产物M1在0.3-61 ng / ml范围内呈线性变化,相对于R.S.D.浓度低于最低定量限(LLOQ)(R.S.D. <11%)的情况下,浓度低于8%。尼群地平的代谢物的LLOQ分别为0.25和0.3 ng / ml。尼群地平的分析回收率为94%,吡啶代谢产物M1的分析回收率为89%。该GC-ECD方法被开发用于临床药代动力学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号